patients with idiopathic membranous
nephropathy: A cohort study," American Journal of Clinical Pathology, vol.
But recent data suggests the inability of micro albuminuria changes to foresee the
nephropathy progression because in at least 33% of patients renal decline has already ensued.2,4 Similarly, derangement of GFR is an indicator of DN but it can only detect the disease when it has progressed to incurable stage.5,6 Apart from these; conventional methods such as assessment of blood urea nitrogen and creatinine are routinely used but are quite insensitive and nonspecific, especially in the setting of acute kidney injury (AKI) in perspective of DN.
The global diabetic
nephropathy market is growing pervasively, mainly due to the technological advancements happened in diabetic care.
TMX-049, is a late phase 2b stage program to treat type 2 diabetic
nephropathy (T2DN), under a co-development agreement with Japan's Teijin Pharma Limited, pursuant to a non-binding Letter of Intent.
"We found that rituximab was noninferior to cyclosporine in inducing proteinuria remission at 12 months and was superior in maintaining long-term proteinuria remission up to 24 months in patients with membranous
nephropathy who were at high risk for progressive disease," the authors write.
IgA
nephropathy (IgAN), also known as Berger's disease, is the most common form of glomerulonephritis, a chronic inflammatory condition of the kidney.
My patient was a case of IgA
nephropathy, RPRF course, extensive crescents with >50% global sclerosis.
The renal biopsy results for CKD in patients with DM could be divided into two categories: Diabetic
nephropathy (DN) and nondiabetic renal disease (NDRD).
Key words: Renal biopsy, antiphospholipid syndrome
nephropathy, lupus nephritis, thrombotic microangiopathy, systemic lupus erythematosus.
The trial included 50 participants with diabetic
nephropathy who, for 12 weeks, received either 100 mg of CoQ10 per day or a placebo.
Anticoagulant-related
nephropathy is a form of acute kidney injury caused by excessive anticoagulation.
Group A consisted of 210 patients who didn't develop contrast-induced
nephropathy (CIN) after catheterization of coronary artery.
